Trelegy ellipta 100-62.5-25 60S
Ended Awarded
- Contract number
- SPE2DR26F92UB
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3 Part of Cencora, Inc.
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $17,542
Award facts
- Contract value 100% obligated
- $17,542.13 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency issued a $17,542.13 delivery order to Amerisourcebergen Drug Corp on June 26, 2026, for TRELEGY ELLIPTA 100-62.5-25 inhalant medication, with final delivery due June 29, 2026.
Place of performance is Conshohocken, PA. The order is priced firm fixed-price and carries no set-aside. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and serves as the execution entity for DLA pharmaceutical distribution within that parent structure.
Quick answers
Who was awarded contract SPE2DR26F92UB?
SPE2DR26F92UB was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on June 26, 2026.
How much is contract SPE2DR26F92UB worth?
The government has obligated $17,542 on SPE2DR26F92UB.
Is contract SPE2DR26F92UB an order under another contract?
Yes. SPE2DR26F92UB is a delivery order under SPE2DR25D2103, an indefinite delivery contract.
Was contract SPE2DR26F92UB competed?
The extent of competition for SPE2DR26F92UB was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award